CIK: 0001609251 · Show all filings
Period: Q1 2025 (← Previous) (Next →)
Filing Date: May 15, 2025
Total Value ($000): $181 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| EXEL | EXELIXIS INC | 878,533 | $32 | 17.9% | $18.73 | +90.2% | COM | 30161Q104 |
| UTHR | UNITED THERAPEUTICS CORP | 98,228 | $30 | 16.7% | $141.46 | +142.3% | COM | 91307C102 |
| CAH | CARDINAL HEALTH INC | 188,745 | $26 | 14.4% | $56.53 | +122.7% | COM | 14149Y108 |
| SUPN | SUPERNUS PHARMACEUTICALS INC | 431,986 | $14 | 7.8% | $35.44 | 0.0% | COM | 868459108 |
| JAZZ | JAZZ PHARMACEUTICALS PLC | 100,703 | $13 | 6.9% | $123.54 | +5.6% | COM | G50871105 |
| ENTA | ENANTA PHARMACEUTICALS INC | 2,116,586 | $12 | 6.5% | $22.16 | -72.1% | COM | 29251M106 |
| GSK | GSK PLC-SPON ADR | 272,000 | $11 | 5.8% | $0.04 | — | COM | 37733W204 |
| — | INDIVIOR PLC | 965,368 | $9 | 5.1% | $0.01 | — | COM | G4766E116 |
| SNY | SANOFI-ADR | 149,096 | $8 | 4.6% | $0.05 | — | COM | 80105N105 |
| BNTX | BIONTECH SE-ADR | 87,563 | $8 | 4.4% | $0.09 | — | COM | 09075V102 |
| — | AVADEL PHARMACEUTICALS | 950,000 | $7 | 4.1% | $0.01 | — | COM | G29687103 |
| ALKS | ALKERMES PLC | 207,822 | $7 | 3.8% | $18.83 | +73.2% | COM | G01767105 |
| VNDA | VANDA PHARMACEUTICALS INC | 754,381 | $3 | 1.9% | $4.91 | -5.1% | COM | 921659108 |
| — | MURAL ONCOLOGY PLC | 70,263 | $0 | 0.0% | $0.01 | — | COM | G63365103 |